DETROIT (WXYZ) — Henry Ford Health System has received more than $440,000 in grants for research into pancreatic cancer.
The grants come from the U CAN-CER VIVE Foundation, which is the philanthropic are of the LaFontaine Automotive Group. They will be used to support the research in two fields.
According to a news released, a $391,000 grant, which is spread over two years, will support research by Dr. Gazala Khan into “the development of a novel treatment approach utilizing a whole genomic sequencing platform to perform DNA and RNA sequencing of patient tumors before and after chemotherapy.”
That research could lead to personalized treatment programs.
The second grants, totaling over $48,000 over two years, will support the research of Fred Valeriote, PH.D., into natural compounds with the potential for treating pancreatic cancer.
“We are thrilled to partner with the U CAN-CER VIVE Foundation to advance innovative research into pancreatic cancer,” said Mary Jane Vogt in a news release. She is senior vice president and chief development officer, Henry Ford Health System. “We deeply appreciate their commitment to supporting cancer research that will impact the lives of so many.”
“The amazing research the dedicated team at Henry Ford Health System is doing toward creating a cancer free world should be applauded,” said Kelley LaFontaine, founder, U CAN-CER VIVE, in a news release. “Ryan and I are confident these grants will move this necessary research in the right direction.”